Hence, the lack of the new high-prevalence antigen, CRUE, is most likely because of substitution of p. Leu217Trp. The CRAG antigen was discovered by failure of any weakly VEGFR-2-IN-5 reactive antibody to a undetermined high-prevalence antigen to react with -chymotrypsin-treated
This was accompanied by a rapid translocation of 5-LOX from nucleus to cytoplasm in both ECs and VSMCs, potentially facilitating SPM biosynthesis
This was accompanied by a rapid translocation of 5-LOX from nucleus to cytoplasm in both ECs and VSMCs, potentially facilitating SPM biosynthesis. D1 (RvD1) and other D-series resolvins and protectins. This was accompanied by a rapid translocation of 5-LOX from